{"anticipatedPostingDate":"2027-01","denomUnitsSelected":"Participants","reportingStatus":"NOT_POSTED","timeFrame":"Day 1 (Cycles 1, 2, 3, 5, 7, 9, 11, 13), Day 2 (Cycle 1)","title":"Number of Participants With Anti-Amivantamab Antibodies","type":"SECONDARY"}